Skip to content

Prevalence and factors associated with sarcopenia in stroke patients

Prevalence sarcopenia in stroke: Cross-sectional descriptive study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210201004
Enrollment
98
Registered
2021-02-01
Start date
2020-09-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic stroke patients onset above 6 month with age above 40 years sarcopenia prevalence sarcopenia sarcopenia in stroke stroke related sarcopenia

Interventions

Diagnosis sarcopenia in stroke patient,Diagnosis non sarcopenia in stroke patient
Diagnostic,Diagnostic

Sponsors

Khon Kaen university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Stroke onset above 6 months 2.Able to walk without personal assistance, with or without gait aid, for at least 10 meters 3.Able to consent to participate in this study

Exclusion criteria

Exclusion criteria: 1.Using medication that may affect body weight or composition e.g. steroids, hormones, diuretics, etc. 2.Having underlying diseases (aside from stroke) that may affect walking performance e.g. unstable angina, congestive heart failure, severe peripheral arterial disease, end-stage organ disease, recent fracture of lower extremity 3.Chronic pain conditions 4.Inability to understand or follow commands

Design outcomes

Primary

MeasureTime frame
Prevalence sarcopenia in stroke N/A Handgrip strength, gait speed, Dual energy Xray absorptiometry

Secondary

MeasureTime frame
factor associated sarcopenia in stroke N/A Handgrip strength, gait speed, Dual energy Xray absorptiometry

Countries

Thailand

Contacts

Public ContactCharuwan Nimphan

Physical medicine and Rehabilitation

charuwan_new@hotmail.com0873074397

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026